Oral presentation to include topline efficacy and safety data for 6 patients with up to 9 months of follow up​Enrollment for registrational Phase ...

Eli Lilly's olomorasib with Merck's Keytruda receives FDA Breakthrough Therapy status for KRAS G12c lung cancer, supported by ...

Thank you for your interest. You can now access the asset below. This annual ranking of the leading national and local firms also includes data analysis, as well as their chief executives' take on the ...

These nuggets are out of bounds. US Open attendees are calling caviar-topped chicken nuggets sold at the food court for a staggering $100 a whopping double-fault — but the opulent offering still ...

PDS Biotech has reported final phase 2 data on PDS0101 in the tough-to-treat head and neck cancer setting, linking a combination of the immunotherapy and Keytruda to median overall survival (OS) of 39 ...

It may not have happened at 2:17 a.m., but “Weapons” has reached a major box office milestone. Director and writer Zach Cregger‘s horror hit, about 17 school children from the same class who ...

Sanuj is a tech enthusiast with a passion for exploring smartphones, tablets, and smart wearables. He started his tech journey with a Lumia smartphone, diving into Windows Phone. Later, he switched to ...

'100 Foot' Waves Are Reportedly Heading For The U.S. originally appeared on The Spun. Hurricane Erin is heading for the United States and so, too, could some massive waves, reaching more than 100 feet ...

Manufacturing in Ireland has long helped many American drug companies pay lower taxes. But that strategy was designed for a world without President Trump’s tariffs. By Rebecca Robbins President ...

Keytruda and Padcev combination improved survival in muscle-invasive bladder cancer patients ineligible for cisplatin-based chemotherapy. The KEYNOTE-905 trial showed significant event-free survival ...

PADCEV plus KEYTRUDA is the first and only regimen to improve survival when used before and after standard of care (surgical cystectomy) in cisplatin-ineligible patients with muscle-invasive bladder ...

Matthew Herper covers medical innovation — both its promise and its perils. Pfizer said Tuesday that its antibody-drug conjugate Padcev extended survival when combined with the cancer immunotherapy ...